Growth Metrics

Guardant Health (GH) Return on Capital Employed (2018 - 2026)

Guardant Health's Return on Capital Employed history spans 8 years, with the latest figure at 32.57% for Q4 2025.

  • On a quarterly basis, Return on Capital Employed rose 191.0% to 32.57% in Q4 2025 year-over-year; TTM through Dec 2025 was 32.57%, a 191.0% increase, with the full-year FY2025 number at 30.22%, up 123.0% from a year prior.
  • Return on Capital Employed hit 32.57% in Q4 2025 for Guardant Health, up from 41.44% in the prior quarter.
  • Over the last five years, Return on Capital Employed for GH hit a ceiling of 14.81% in Q1 2021 and a floor of 41.9% in Q2 2025.
  • Historically, Return on Capital Employed has averaged 31.38% across 5 years, with a median of 34.62% in 2024.
  • Biggest five-year swings in Return on Capital Employed: crashed -1891bps in 2023 and later surged 615bps in 2024.
  • Tracing GH's Return on Capital Employed over 5 years: stood at 20.34% in 2021, then crashed by -83bps to 37.22% in 2022, then rose by 4bps to 35.61% in 2023, then grew by 3bps to 34.48% in 2024, then grew by 6bps to 32.57% in 2025.
  • Business Quant data shows Return on Capital Employed for GH at 32.57% in Q4 2025, 41.44% in Q3 2025, and 41.9% in Q2 2025.